Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Giorgio Lorenzo Colombo, Calogero Cammà, Adolfo Francesco Attili, Roberto Ganga, Giovanni Battista Gaeta, Giuseppina Brancaccio, Jean Marie Franzini, Marco Volpe & Giuseppe Turchetti. (2015) Patterns of treatment and costs of intermediate and advanced hepatocellular carcinoma management in four Italian centers. Therapeutics and Clinical Risk Management 11, pages 1603-1612.
Read now
Read now
Giuseppe Cabibbo, Silvia Tremosini, Giovanni Galati, Giancarlo Mazza, Gennaro Gadaleta-Caldarola, Giuseppe Lombardi, Michela Antonucci & Rodolfo Sacco. (2014) Transarterial chemoembolization and sorafenib in hepatocellular carcinoma. Expert Review of Anticancer Therapy 14:7, pages 831-845.
Read now
Read now
Articles from other publishers (12)
Saur Hajiev, Elias Allara, Leila Motedayеn Aval, Tadaaki Arizumi, Dominik Bettinger, Mario Pirisi, Lorenza Rimassa, Tiziana Pressiani, Nicola Personeni, Laura Giordano, Masatoshi Kudo, Robert Thimme, Joong-Won Park, Tamar H. Taddei, David E. Kaplan, Ramya Ramaswami, David J. Pinato & Rohini Sharma. (2020) Impact of age on sorafenib outcomes in hepatocellular carcinoma: an international cohort study. British Journal of Cancer 124:2, pages 407-413.
Crossref
Crossref
Francesca Romana Ponziani, Giulia Gibiino & Antonio Gasbarrini. 2018. Surgical Management of Elderly Patients. Surgical Management of Elderly Patients
335
346
.
Nages Nagaratnam, Kujan Nagaratnam & Gary CheukNages Nagaratnam, Kujan Nagaratnam & Gary Cheuk. 2018. Geriatric Diseases. Geriatric Diseases
217
220
.
Nages Nagaratnam, Kujan Nagaratnam & Gary CheukNages Nagaratnam, Kujan Nagaratnam & Gary Cheuk. 2017. Geriatric Diseases. Geriatric Diseases
1
4
.
G. de Stefano, V. Iodice & N. Farella. (2015) Complete Response to Full-Dose Sorafenib Treatment in an Elderly HCC Patient: a Case Report. Journal of Gastrointestinal Cancer 46:4, pages 430-433.
Crossref
Crossref
Rodolfo Sacco, Michela Antonucci, Irene Bargellini, Sara Marceglia, Valeria Mismas & Giuseppe Cabibbo. (2015) Transarterial chemoembolization and sorafenib in patients with intermediate-stage hepatocellular carcinoma: time to enter routine clinical practice?. Future Oncology 11:17, pages 2371-2373.
Crossref
Crossref
Andrea Mancuso, Alessandra Mazzola, Giuseppe Cabibbo, Giovanni Perricone, Marco Enea, Antonio Galvano, Claudio Zavaglia, Luca Belli & Calogero Cammà. (2015) Survival of patients treated with sorafenib for hepatocellular carcinoma recurrence after liver transplantation: A systematic review and meta-analysis. Digestive and Liver Disease 47:4, pages 324-330.
Crossref
Crossref
Luigi Bolondi, Antonio Craxi, Franco Trevisani, Bruno Daniele, Giovan Giuseppe Di Costanzo, Stefano Fagiuoli, Calogero Cammà, Paolo Bruzzi, Romano Danesi, Federico Spandonaro, Corrado Boni, Armando Santoro & Massimo Colombo. (2015) Refining sorafenib therapy: lessons from clinical practice. Future Oncology 11:3, pages 449-465.
Crossref
Crossref
Mauro Borzio. (2015) Management of hepatocellular carcinoma in the elderly. World Journal of Hepatology 7:11, pages 1521.
Crossref
Crossref
Dong-Sheng Zhou. (2015) Inflammation scores predict survival for hepatitis B virus-related hepatocellular carcinoma patients after transarterial chemoembolization. World Journal of Gastroenterology 21:18, pages 5582.
Crossref
Crossref
Giuseppe Cabibbo, Salvatore Petta, Marcello Maida & Calogero Cammà. (2015) Sorafenib for Hepatocellular Carcinoma: From Randomized Controlled Trials to Clinical Practice. Digestive Diseases 33:5, pages 668-674.
Crossref
Crossref
Julien Edeline, Laurence Crouzet, Samuel Le Sourd, Claire Larible, Angélique Brunot, Florence Le Roy, Catherine Cattenoz, Marianne Latournerie, Daniel Gédouin, Anne Guillygomarc’h & Eveline Boucher. (2014) Sorafenib use in elderly patients with hepatocellular carcinoma: caution about use of platelet aggregation inhibitors. Cancer Chemotherapy and Pharmacology 75:1, pages 215-219.
Crossref
Crossref